Ticker EARS – Auris Medical – sales, description, marketcap – Tickerday.com

EARS

Auris Medical

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 3.75M; Volume: 60.62K; AvgVol 3m: 1.28M; Beta: 0.48;

Cost estimate:

P/E: –; EPS: -2.48; EPS growth quarter/prev quarter: 77.40%;

EPS growth this year: 84.20%; EPS growth past 5 years: 55.50%;

EPS ttm: -2.48;

P/S: ; P/B: 0.36; P/Cashflow: 2.54; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -68.20%; ROE – return on equity: -148.20%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 8.70%; Insider Transactions:0.00%;

Institutional Ownership: 2.60%; Institutional Transactions: 2.53%;

Data update: 07/10/2020.